5 studies found for: cholangiocarcinoma AND amsterdam type | Open Studies
Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma
Metformin And Chloroquine in IDH1/2-mutated Solid Tumors
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
|4||Not yet recruiting||
SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Observation After Curative Intent Resection of Biliary Tract Cancer
† Study has passed its completion date and status has not been verified in more than two years.